The clinical relevance of AI.
FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum’s IPO in South Korea
Plus, news about Caliway Pharmaceuticals, argenx, Halozyme Therapeutics, Verrica, Liquidia and Pharmosa: FDA lifts partial clinical hold on Avidity Biosciences’ drug: Sign up to read